Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603590.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
-13%
0.06
vs 0.07
Q1.23
-45%
0.16
vs 0.3
Q2.23
+87%
0.43
vs 0.23
Q3.23
+154%
0.36
vs 0.14
Q4.23
N/A
-0.08
vs 0.06
Q1.24
+65%
0.27
vs 0.16
Q2.24
-45%
0.24
vs 0.43
Q3.24
-40%
0.21
vs 0.36
Q4.24
N/A
-0.45
vs -0.08
Q1.25
+4%
0.28
vs 0.27
Sales Growth
YoY
Current
Estimates
Q4.22
+31%
278.7M vs 213.2M
Q1.23
+6%
165.1M vs 156.2M
Q2.23
+33%
285.7M vs 215.4M
Q3.23
+24%
269.2M vs 216.4M
Q4.23
-28%
200M vs 278.7M
Q1.24
+21%
199.2M vs 165.1M
Q2.24
-29%
203.7M vs 285.7M
Q3.24
-10%
241.3M vs 269.2M
Q4.24
-10%
179.1M vs 200M
Q1.25
+6%
212M vs 199.2M
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.01
Q3.23
+2%
0.02
vs 0.02
Q4.23
0%
-0.00
vs 0.02
Q1.24
+1%
0.01
vs -0.00
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
-2%
-0.02
vs 0.01
Q1.25
+1%
0.01
vs -0.02
Institutionnal Ownership
Forecast
435%2026-Revenue
296%2026-EPS
324%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research, production, and sale of various drugs in China. The company offers Su Ling product in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It also engages in the development of drug candidates, including CX1026, CX1003, and KC1036. The company was founded in 2003 and is headquartered in Beijing, China.
SHH
EPS improving
EPS improving
3.23Â ( 7.94%)
Relative Strenght
Volume Buzz
426%
Earning Acce
No
Dist 52w H.
2%Relative Strength
603590.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603590.SS compares to sector?